Alnylam Pharmaceuticals President and Chief Executive Officer John Maraganore and Invitrogen CEO Greg Lucier have been appointed to the board of directors of the Biotechnology Industry Organization.
Maraganore and Lucier will serve three-year terms.
Sigma-Aldrich has named Carl Turza chief information officer, effective May 1.
Turza has worked at W.W. Grainger, AlliedSignal Aerospace, and other "large and complex" organizations, Sigma-Aldrich said. He holds an MBA from the University of Illinois in Chicago and a BA in economics from the University of Illinois in Champaign.
Applied Biosystems announced this week that Mark Stevenson has been appointed president of the firm's molecular biology division. He previously served as president of the firm's applied markets division.
Stevenson succeeds William Murray, who has resigned due to personal reasons.
ABI also announced that Leonard Klevan has replaced Stevenson as president of the applied markets division. Klevan had joined ABI earlier this year as vice president of R&D for applied markets.
Before joining ABI, he was CEO of ReliaGene Technologies. He also is a former president and CEO of MiraiBio, a subsidiary of Hitachi Software Engineering, and had managed technology acquisitions and business development at Life Technologies, which was acquired by Invitrogen in 2000.